A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs.
Bagot M, Hasan B, Whittaker S, Beylot-Barry M, Knobler R, Shah E, Marreaud S, Morris S, Dalle S, Servitje O, Cowan R, Väkevä L, Chaby G, Jonak C, Fox CP, Ritchie D, Vermeer MH, Stadler R, Romero PLO, Scarisbrick J, Quaglino P.
Bagot M, et al. Among authors: morris s.
Eur J Dermatol. 2017 Jun 1;27(3):286-294. doi: 10.1684/ejd.2017.3008.
Eur J Dermatol. 2017.
PMID: 28468739
Clinical Trial.